Clari Vest Asset Management LLC Allogene Therapeutics, Inc. Transaction History

Clari Vest Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$13.13 - $24.52 $215,725 - $402,863	-16,430 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$21.01 - $27.64 $14,244 - $18,739	-678 Reduced 3.96%	16,430 $423,000
Q2 2021 Aug 09, 2021	BUY	$23.49 - $35.8 $159,356 - $242,867	6,784 Added 65.71%	17,108 $447,000
Q1 2021 May 13, 2021	BUY	$25.79 - $39.02 $43,868 - $66,373	1,701 Added 19.73%	10,324 $364,000
Q4 2020 Feb 09, 2021	SELL	$25.24 - $43.45 $296,115 - $509,755	-11,732 Reduced 57.64%	8,623 $218,000
Q3 2020 Nov 09, 2020	SELL	$32.38 - $44.96 $30,825 - $42,801	-952 Reduced 4.47%	20,355 $768,000
Q2 2020 Aug 12, 2020	BUY	$18.39 - $54.04 $391,835 - $1.15 Million	21,307 New	21,307 $913,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.